Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma. - Martínez-Vila, Clara; Teixido, Cristina; Martín, Roberto; Aya, Francisco; Sudhaman, Sumedha; Budde, Griffin L.; González-Navarro, Europa Azucena; Alos, Llucia; Castrejon, Natalia; Ortiz, J. Bryce; Krainock, Michael; Liu, Minetta C.; et al. (Cancers, 2025)